Charcot-Marie-Tooth disease sounds as though it involves three people, a complicated dental procedure, or possibly both. In reality, it is a group of inherited disorders that damage the peripheral nervesthe long communication lines carrying movement and sensation signals between the brain, spinal cord, muscles, and skin. CMT was named for the three physicians who described it in 1886, and it is also called hereditary motor and sensory neuropathy.
CMT usually progresses slowly. It most often begins in the feet and lower legs, where weakness, muscle wasting, altered sensation, and foot deformities can make walking less stable. Symptoms may later affect the hands and forearms. Severity varies enormously: one person may need only supportive shoes, while another may use ankle-foot orthoses, mobility aids, or surgery. Most people have a normal life expectancy, but lifelong monitoring matters because falls, injuries, pain, fatigue, and uncommon complications can affect health and independence.
What Is Charcot-Marie-Tooth Disease?
CMT is not one single disease. It is an umbrella term for many genetic peripheral neuropathies with overlapping features. Peripheral nerves contain axons, which function somewhat like electrical wires, and myelin, the insulating material that helps signals travel efficiently. Depending on the CMT subtype, a genetic change may mainly damage the axon, the myelin sheath, or both.
The longest nerves are particularly vulnerable, which helps explain why problems usually show up first in the toes, feet, ankles, and lower legs. When motor nerves cannot activate muscles effectively, muscles weaken and shrink. When sensory nerves are affected, a person may experience numbness, tingling, burning, reduced vibration sense, or difficulty detecting heat, cold, and pain.
That combination can turn an unnoticed blister into a much bigger problem, so foot care is not merely cosmeticit is preventive medicine. CMT should not be confused with Charcot foot, a destructive joint condition most commonly associated with severe neuropathy and diabetes. The names are similar, but the disorders are different.
Common Symptoms of CMT
Symptoms can begin in early childhood, adolescence, adulthood, or, less commonly, later life. Even relatives with the same genetic variant may have different ages of onset and levels of disability. The pattern is usually symmetrical, meaning both sides of the body are affected, although one side can seem worse.
Foot and Leg Symptoms
- Frequent tripping, stumbling, or ankle sprains
- Foot drop, which makes it difficult to lift the front of the foot
- High arches, flat feet, hammertoes, or other foot deformities
- Weak ankles and an unsteady or high-stepping gait
- Muscle wasting in the calves, sometimes producing an “inverted champagne bottle” leg shape
- Reduced reflexes, especially at the ankles
- Numbness, tingling, burning, cramping, or neuropathic pain
- Poor balance, especially in darkness or on uneven ground
Hand and Arm Symptoms
As CMT progresses, weakness may reach the hands and forearms. People may struggle with buttons, zippers, handwriting, jar lids, keys, phone grips, cooking tools, or prolonged typing. Hand tremor can occur in some subtypes. Occupational therapy and adaptive devices often make these tasks much less frustrating.
Other Possible Problems
Some people develop scoliosis, hip problems, joint contractures, chronic fatigue, sleep-related breathing problems, or hearing loss. Certain rare genetic subtypes may involve breathing, swallowing, vocal cords, vision, or other body systems.
These features are not typical for everyone, but new shortness of breath, swallowing trouble, major voice changes, or rapid loss of function deserves prompt medical evaluation. A sudden decline should not automatically be blamed on CMT, since another treatable condition may be responsible.
What Causes Charcot-Marie-Tooth Disease?
CMT is caused by disease-related changes in genes needed for healthy peripheral nerves. More than 100 genes are linked to CMT, and additional genetic causes continue to be identified. Common examples include PMP22, MPZ, GJB1, and MFN2. A duplication involving PMP22 is the usual cause of CMT1A, the most common subtype.
Inheritance may be autosomal dominant, autosomal recessive, or X-linked. In an autosomal dominant form, one altered copy of a gene can cause disease, and an affected parent generally has a 50% chance of passing the variant to each child.
Autosomal recessive forms usually require altered copies from both parents. Parents who each carry one altered copy may have no symptoms themselves. When both parents carry a variant in the same recessive CMT gene, each pregnancy typically has a 25% chance of producing an affected child.
X-linked CMT follows a different pattern because the responsible gene is on the X chromosome. A person can also have CMT because of a new genetic change that was not identified in either parent, so the absence of a family history does not rule it out.
Genetic counseling can translate these patterns into information relevant to a specific family. It can also help people understand test results, reproductive options, and why a variant of uncertain significance is not the same as a confirmed genetic diagnosis.
Main Types of Charcot-Marie-Tooth Disease
Traditional CMT names combine nerve-conduction findings, inheritance patterns, and sometimes the responsible gene. Modern specialists increasingly use gene-based descriptions because the older numbering system has become crowded enough to resemble an overbooked airline seating chart.
CMT1: Primarily Demyelinating
CMT1 mainly affects myelin and usually causes clearly slowed nerve-conduction velocities. CMT1A, commonly linked to a PMP22 duplication, accounts for a large share of diagnosed CMT. CMT1B is often associated with changes in MPZ.
Symptoms commonly start in childhood or adolescence and include distal weakness, high arches, foot drop, sensory changes, and reduced reflexes. Progression is usually slow, although severity can vary even within one family.
CMT2: Primarily Axonal
CMT2 mainly damages the axon itself. Nerve signals may travel at relatively preserved speeds, but the strength of the recorded response is reduced because fewer axons function normally.
CMT2 includes many gene-specific subtypes. MFN2-related CMT2A is among the better-known examples. Onset and severity vary, and some forms have additional features involving vision, hearing, breathing, or the upper limbs.
CMTX: X-Linked CMT
The most common X-linked form is associated with GJB1. Males often have more pronounced symptoms because they have one X chromosome, while females may range from minimally affected to moderately affected.
An affected father does not pass an X-linked variant to his sons, but he passes his X chromosome to all daughters. A woman carrying a disease-related GJB1 variant generally has a 50% chance of passing it to each child.
CMT4 and Other Recessive Forms
CMT4 traditionally refers to several autosomal recessive neuropathies that may affect myelin, axons, or both. Some begin early and progress more severely, although the exact course depends on the gene. For example, SH3TC2-related CMT4C is frequently associated with childhood-onset scoliosis as well as peripheral neuropathy.
Intermediate CMT
Intermediate forms have nerve-conduction findings between the classic demyelinating and axonal categories. Both the myelin and the axon may be affected, making a precise genetic diagnosis especially useful.
Severe Early-Onset Forms
Severe early-onset neuropathies may begin in infancy or early childhood with low muscle tone, delayed motor milestones, marked weakness, sensory loss, or significant skeletal deformity. These children benefit from evaluation at a pediatric neuromuscular center because care may involve neurology, genetics, rehabilitation, pulmonology, and orthopedics.
How CMT Is Diagnosed
Diagnosis begins with a detailed history and neurologic examination. The clinician looks for distal weakness, muscle wasting, foot shape, gait changes, sensory loss, reflex abnormalities, and patterns among relatives.
Because diabetes, vitamin deficiencies, autoimmune neuropathies, medication toxicity, and other conditions can also damage peripheral nerves, the evaluation may include blood tests or other studies to rule out acquired causes. This is important because not every person with high arches and numb feet has CMT.
Nerve-Conduction Studies and Electromyography
Nerve-conduction studies measure how quickly and strongly electrical signals move through peripheral nerves. Slow conduction often points toward myelin damage, while relatively preserved speed with weak responses may suggest axonal loss.
Electromyography, commonly called EMG, evaluates electrical activity in selected muscles. Together, nerve-conduction studies and EMG help characterize the neuropathy and guide genetic testing.
Genetic Testing
Genetic testing may confirm the diagnosis, identify the subtype, clarify inheritance, support family planning, and determine eligibility for subtype-specific research. Testing may start with a common change such as the PMP22 duplication or use a multigene panel from the beginning.
Broader sequencing may be considered when initial testing is negative. A negative result does not always exclude CMT because some causative variants remain unknown or cannot be detected reliably with the test that was used.
When Additional Testing Is Needed
Imaging, breathing tests, hearing evaluation, sleep studies, or orthopedic assessment may be recommended when symptoms point to specific complications. Nerve biopsy is now uncommon and is generally reserved for unusual diagnostic situations in which other tests have not provided an answer.
Treatment and Long-Term Management
As of July 2026, there is no cure or FDA-approved disease-modifying treatment that works across CMT types. Current treatment focuses on preserving function, reducing symptoms, preventing injuries, and supporting participation in school, work, family life, and recreation.
Because CMT varies by person and genetic subtype, the best plan is multidisciplinary and periodically updated. A typical care team may include a neurologist, physical therapist, occupational therapist, orthotist, podiatrist, orthopedic surgeon, genetic counselor, and primary care professional.
Physical Therapy and Exercise
Physical therapy may address flexibility, balance, gait, posture, endurance, and safe strengthening. Stretching can help limit tightening of the Achilles tendons and other joints. Gait training may reduce compensatory movements that otherwise contribute to fatigue or pain.
Low-impact aerobic activity, swimming, cycling, and appropriately scaled resistance exercise may support conditioning without treating every workout like an audition for an action movie. Exercise should be individualized, especially when weakness, pain, severe fatigue, or joint instability is present.
Exercise does not repair the underlying genetic nerve damage, but it can support cardiovascular health, mobility, confidence, and overall function. A therapist familiar with neuromuscular conditions can help establish a sensible intensity and recovery schedule.
Occupational Therapy
Occupational therapists help protect hand function and simplify daily tasks. Solutions may include larger pen grips, ergonomic keyboards, adapted kitchen tools, splints, zipper pulls, voice-to-text software, or changes in how workstations are arranged.
Energy-conservation strategies can also help people spend less effort on routine tasks and more on activities they value. The goal is not necessarily to perform every task in the traditional way; it is to perform it safely, efficiently, and independently.
Braces, Shoes, and Mobility Aids
Ankle-foot orthoses, or AFOs, can improve toe clearance, stabilize weak ankles, reduce falls, and make walking more efficient. The most appropriate design depends on muscle strength, joint flexibility, walking pattern, footwear, and lifestyle.
Supportive or custom footwear may accommodate high arches, pressure points, or toe deformities. Canes, trekking poles, scooters, or wheelchairs are useful tools when needednot proof that someone has “given up.” The correct mobility device can preserve energy and expand independence.
Pain and Cramp Management
Pain may come from abnormal joints and muscles, nerve damage, poorly fitting braces, pressure points, or overuse. Treatment depends on the cause and may involve therapy, orthotic adjustments, footwear changes, or medication for neuropathic or musculoskeletal pain.
Medication decisions should be individualized because some drugs can worsen peripheral neuropathy. Vincristine is a well-established concern in demyelinating CMT. Every clinician should know about the diagnosis before prescribing chemotherapy or another potentially neurotoxic medicine. Patients should not stop a prescribed medication without discussing the risks and alternatives with the prescribing professional.
Orthopedic Surgery
Surgery may be considered for painful or rigid foot deformities, severe instability, progressive contractures, or difficulty fitting braces and shoes. Procedures can rebalance tendons, correct bone alignment, straighten toes, or stabilize joints.
Timing matters. Surgery performed before a deformity becomes completely rigid may provide more options, but every procedure must account for the underlying muscle imbalance. The goal is a more stable and functional foot, not simply a more photogenic X-ray.
Foot Care and Injury Prevention
Reduced sensation increases the risk of unnoticed cuts, burns, pressure injuries, and infections. Daily foot inspection, properly fitted shoes, careful nail care, and prompt attention to redness or broken skin are practical safeguards.
Fall prevention may include better lighting, handrails, uncluttered walkways, nonslip bathroom surfaces, and removal of loose rugs that behave like tiny household villains. A home assessment can identify hazards that are easy to overlook.
Prognosis and When to Seek Medical Care
CMT commonly worsens gradually, often over decades, and most people remain active with appropriate support. The condition usually does not shorten life expectancy, although rare subtypes involving breathing or other organ systems can be more serious.
Progression is not always smooth. Growth spurts, pregnancy, illness, injury, inactivity, weight changes, arthritis, or aging may make limitations more noticeable. A sudden or rapid decline is not typical and should prompt evaluation for an additional medical problem.
Contact a healthcare professional for increasing falls, new weakness, persistent pain, a nonhealing foot wound, worsening deformity, or difficulty performing daily tasks. Seek urgent care for sudden weakness, significant breathing or swallowing difficulty, or signs of a serious foot infection.
Regular follow-up with a neurologist or neuromuscular clinic can identify changes before they become avoidable crises. Braces that worked perfectly five years ago may no longer match the person’s body, gait, or daily activities.
Research and the Future of CMT Care
CMT research is increasingly organized by genetic subtype. Investigators are studying gene replacement, gene silencing, antisense approaches, small molecules, nerve and muscle targets, and improved methods for delivering therapies to peripheral nerves.
Researchers are also developing better outcome measures for clinical trials. Natural-history studies are essential because scientists must understand how each subtype changes over time before they can determine whether an experimental treatment has altered that course.
Clinical-trial participation is not appropriate for everyone, and an orphan-drug designation or early trial does not mean a therapy is proven or FDA-approved. Early studies primarily examine safety, dosage, biological activity, or preliminary signs of benefit.
Still, the expanding research pipeline is encouraging. A confirmed genetic diagnosis may become increasingly useful as experimental treatments become more subtype-specific. People interested in research should discuss opportunities with a CMT specialist and verify trial details through recognized registries.
Living With CMT: Composite Day-to-Day Experiences
The following examples are composites based on commonly reported challenges in CMT care. They are not quotations from, or medical histories of, any single patient.
The Student Who Keeps Tripping
A middle-school student may be labeled clumsy because gym class involves repeated falls, slow running, and ankles that seem to roll without submitting a calendar invitation. High arches and weak ankle dorsiflexion may have been present for years, but the pattern becomes obvious during a growth spurt.
After evaluation, the student receives lightweight ankle-foot orthoses and a school plan allowing extra transition time, elevator access when needed, and alternatives to high-impact activities. The biggest improvement may not be speed; it may be relief from believing the problem was laziness.
The Adult Who Finally Connects the Family Dots
An adult might seek care after noticing foot drop, hand fatigue, and repeated ankle sprains. During the family-history discussion, several seemingly unrelated facts suddenly line up: a parent wore unusually rigid shoes, an uncle had very thin lower legs, and a grandparent stopped using buttons.
Nerve studies suggest an inherited neuropathy, and genetic testing identifies a CMT subtype. The diagnosis may bring mixed emotionsvalidation, worry about children, and frustration that it took so long. Genetic counseling helps replace vague fear with specific probabilities and choices.
The Worker Adapting Without Stepping Away
A graphic designer with hand weakness may find that a standard mouse, long typing sessions, and tiny shortcut keys produce cramps and fatigue. An occupational therapist recommends a vertical mouse, customized keyboard commands, speech recognition, scheduled microbreaks, and a different desk height.
These are not dramatic interventions, but together they can preserve productivity. Workplace accommodations may also include closer parking, flexibility to alternate sitting and standing, elevator access, or remote work during periods of pain and fatigue.
The Parent Balancing Activity and Fatigue
A parent with CMT may be able to walk through a grocery store but have too little energy left for dinner, baths, and bedtime. Using a mobility scooter for long outings can feel emotionally complicated at first. In practice, it may conserve enough energy to participate more fully with the family.
The value of mobility support is not measured only in steps avoided. It may be measured in the birthday party attended, the museum explored, or the energy still available at the end of the day.
The Older Adult Reassessing a Familiar Condition
Someone who has managed mild CMT for decades may notice more balance trouble with age. The change can come from CMT, ordinary age-related muscle loss, arthritis, vision changes, medication effects, or several factors at once.
A fresh assessment may lead to updated braces, a home-safety review, targeted strength and balance work, and treatment of unrelated contributors. “I already know my CMT” is understandable, but equipment and bodies both change, and neither reads the warranty.
Across these experiences, the most useful care is practical and personal. A successful plan might mean fewer falls, shoes that do not cause pressure sores, enough hand endurance to cook, or the confidence to travel with a folding cane.
CMT management is rarely one grand fix. It is usually a series of smart adjustments that protect independence while research works toward treatments that address the underlying disease.
Conclusion
Charcot-Marie-Tooth disease is a diverse group of inherited peripheral neuropathies, not a one-size-fits-all diagnosis. Muscle weakness, foot deformities, sensory loss, balance problems, and hand difficulties are common, but the age of onset and severity can differ substantially.
Diagnosis combines clinical evaluation, nerve-conduction testing, and, increasingly, genetic testing. Although no cure is currently available, physical and occupational therapy, appropriate exercise, orthoses, pain management, foot care, adaptive technology, mobility aids, and carefully selected surgery can make a meaningful difference.
Early recognition and coordinated care help people protect mobility, prevent complications, and build daily routines around what they want to donot simply around what CMT makes difficult.
